Health Care [ 4/12 ] | Health Care Equipment & Supplies [ 43/72 ]
NASDAQ | Common Stock
Silk Road Medical, Inc. operates as a medical device company in the United States.
The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization.
Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices; and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter, a specialty balloon for the TCAR procedure.
Silk Road Medical, Inc. was incorporated in 2007 and is headquartered in Sunnyvale, California.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Apr 30, 24 | -0.36 Increased by +16.28% | -0.40 Increased by +10.00% |
| Feb 28, 24 | -0.33 Increased by +2.94% | -0.42 Increased by +21.43% |
| Nov 8, 23 | -0.33 Decreased by -13.79% | -0.35 Increased by +5.71% |
| Aug 1, 23 | -0.35 Increased by +18.60% | -0.39 Increased by +10.26% |
| May 9, 23 | -0.43 Increased by +10.42% | -0.39 Decreased by -10.26% |
| Feb 28, 23 | -0.34 Increased by +19.05% | -0.38 Increased by +10.53% |
| Nov 8, 22 | -0.29 Increased by +27.50% | -0.43 Increased by +32.56% |
| Jul 26, 22 | -0.43 Decreased by -38.71% | -0.46 Increased by +6.52% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 23 | 44.44 M Increased by +18.89% | -12.79 M Decreased by -12.06% | Decreased by -28.78% Increased by +5.75% |
| Jun 30, 23 | 45.30 M Increased by +36.55% | -13.48 M Increased by +12.43% | Decreased by -29.77% Increased by +35.87% |
| Mar 31, 23 | 40.13 M Increased by +43.22% | -16.01 M Increased by +4.01% | Decreased by -39.89% Increased by +32.98% |
| Dec 31, 22 | 40.07 M Increased by +41.77% | -12.60 M Increased by +14.26% | Decreased by -31.44% Increased by +39.52% |
| Sep 30, 22 | 37.37 M Increased by +51.31% | -11.41 M Increased by +17.81% | Decreased by -30.53% Increased by +45.68% |
| Jun 30, 22 | 33.17 M Increased by +25.39% | -15.40 M Decreased by -46.10% | Decreased by -46.42% Decreased by -16.52% |
| Mar 31, 22 | 28.02 M Increased by +27.06% | -16.68 M Decreased by -55.97% | Decreased by -59.52% Decreased by -22.75% |
| Dec 31, 21 | 28.27 M Increased by +33.75% | -14.69 M Increased by +12.31% | Decreased by -51.98% Increased by +34.44% |